WG
RYTM icon

Winton Group’s Rhythm Pharmaceuticals RYTM Stock Holding History

Winton Group’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-24,048
Closed -$314K – 1345
2021
Q3 		$314K Buy
24,048
+7,185
+43% +$110K 0.02% 1069
2021
Q2 		$330K Buy
+16,863
New +$350K 0.02% 1139
2020
Q4 		– Sell
-13,159
Closed -$285K – 1485
2020
Q3 		$285K Buy
+13,159
New +$302K 0.01% 1263

Other funds holding RYTM

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Winton Group's RYTM Position: Q4 2021 in Review

Winton Group sold out of Rhythm Pharmaceuticals (RYTM) in Q4 2021, closing a stake of 24,048 shares — an estimated $314K sold.

Winton Group first reported a position in RYTM in Q3 2020 and held it in 3 quarters. The position peaked at $330K in Q2 2021. 98 funds tracked by Wall St. Rank hold RYTM as of Q4 2021.

  • Winton Group reported no remaining Rhythm Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Winton Group sold 24,048 Rhythm Pharmaceuticals shares in Q4 2021, an estimated $314K.
  • Winton Group first reported a position in Rhythm Pharmaceuticals in Q3 2020 and held it in 3 quarters.
  • Winton Group's Rhythm Pharmaceuticals position peaked at $330K in Q2 2021.
  • 98 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q4 2021.

Based on Winton Group's 13F filing for Q4 2021, filed 10 Feb 2022.